128 related articles for article (PubMed ID: 1614086)
1. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
3. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
Hawkins BS;
Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
[TBL] [Abstract][Full Text] [Related]
6. Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma.
Gilson MM; Diener-West M; Hawkins BS
Ophthalmic Epidemiol; 2007; 14(4):251-7. PubMed ID: 17896305
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].
Schmidt JC; Brieden-Azvedo S; Nietgen GW
Klin Monbl Augenheilkd; 2001 Dec; 218(12):800-4. PubMed ID: 11805872
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
11. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
[TBL] [Abstract][Full Text] [Related]
12. Forecasting the prognosis of choroidal melanoma with an artificial neural network.
Kaiserman I; Rosner M; Pe'er J
Ophthalmology; 2005 Sep; 112(9):1608. PubMed ID: 16023213
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
15. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
17. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanomas of the choroid and ruthenium applicators.
Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative irradiation before enucleation in malignant melanoma of the uvea. Review of the literature and initial personal experiences].
Bornfeld N; Huser U; Sauerwein W; Wessing A; Sack H
Klin Monbl Augenheilkd; 1989 Apr; 194(4):252-60. PubMed ID: 2657203
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]